Device Interventions for Heart Failure.

Abstract excerpt

Despite remarkable advances in drug therapy for heart failure (HF), the residual HF-related morbidity, mortality, and hospitalizations remain substantial across all HF phenotypes, and significant proportions of patients with HF remain symptomatic despite optimal drug therapy. Driven by these unmet clinical needs, the exponential growth of transcatheter interventions, and a recent shift in the regulatory landscape...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Phenotype
• Share to Heart Failure
• Share to Hospitalization